Schofield Laboratory for Neuropsychological Outcomes of Oncology Treatment

As a primary investigator on two foundation-funded projects, Dr. Schofield and her team collect longitudinal data regarding neuropsychological functioning in pediatric, adolescent, and young adult patients undergoing oncology intervention. She is specifically interested in neurotoxicity and cognitive sequelae of cellular therapy (e.g., hematopoietic stem cell transplant, chimeric antigen receptor (CAR) T-cell therapy).